Citigroup Maintains Neutral Rating on Regeneron, Raises Price Target to $825
Citigroup raised its price target on Regeneron to $825 per share from $740 while maintaining its Neutral rating.
Citigroup raised its price target on Regeneron to $825 per share from $740 while maintaining its Neutral rating.